Mylan settles with Eisai in Targretin case

18-12-2013

Mylan Pharmaceuticals and its partner Banner Pharmacaps Inc, a subsidiary of Patheon Inc, have entered into a settlement and licence agreement with Japanese pharmaceutical company Eisai Inc and Valeant Pharmaceuticals Luxembourg S.a.r.l.


Mylan, Eisai, Targretin, patent settlement

LSIPR